Todd K. Rosengart, MD
May 20th, 2014
Hopes and Beliefs: How Patients Respond to Informed-Consent Tools
Todd K. Rosengart, MD
Todd Rosengart answers Harlan Krumholz’s questions about his study of informed consent in patients scheduled for PCI.
NEJM Journal Watch — Recent Cardiology Articles- Anticoagulation in Patients with Cancer-Associated Pulmonary Embolism: How Long is Long Enough?
- Spironolactone Use After Percutaneous Intervention for Acute Myocardial Infarction
- CRISPR/Cas9 Gene Editing for Transthyretin Cardiomyopathy
- Does Colchicine Reduce Cardiac Events After Myocardial Infarction?
- First-Line Therapy for Ventricular Tachycardia After MI: What's the Best Approach?